(FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 8.04%585.17M | 7.66%282.84M | 18.67%541.65M | 3.67%262.71M | 3.65%456.43M | 24.39%253.42M | -14.18%440.37M | --203.74M | 14.56%513.15M | --447.92M |
Operating income | 8.04%585.17M | 7.66%282.84M | 18.67%541.65M | 3.67%262.71M | 3.65%456.43M | 24.39%253.42M | -14.18%440.37M | 203.74M | 14.56%513.15M | 447.92M |
Cost of sales | -14.11%-543.33M | -9.89%-253.55M | -19.41%-476.13M | -3.56%-230.74M | -3.18%-398.74M | -21.77%-222.8M | 17.28%-386.45M | ---182.97M | -12.19%-467.15M | ---416.41M |
Operating expenses | -14.11%-543.33M | -9.89%-253.55M | -19.41%-476.13M | -3.56%-230.74M | -3.18%-398.74M | -21.77%-222.8M | 17.28%-386.45M | -182.97M | -12.19%-467.15M | -416.41M |
Gross profit | -36.14%41.84M | -8.39%29.29M | 13.58%65.52M | 4.42%31.97M | 6.98%57.69M | 47.42%30.62M | 17.22%53.92M | 20.77M | 45.98%46M | 31.51M |
Administrative expenses | -0.62%-20.73M | -49.45%-9.91M | -70.47%-20.61M | -20.86%-6.63M | -7.95%-12.09M | -15.04%-5.49M | 20.25%-11.2M | ---4.77M | -14.82%-14.04M | ---12.23M |
Impairment and provision | -42.37%-625K | -100.95%-424K | -221.94%-439K | 42.51%-211K | 266.67%360K | -536.90%-367K | 1.82%-216K | --84K | -50.68%-220K | ---146K |
-Other impairment is provision | -42.37%-625K | -100.95%-424K | -221.94%-439K | 42.51%-211K | 266.67%360K | -536.90%-367K | 1.82%-216K | --84K | -50.68%-220K | ---146K |
Special items of operating profit | -99.14%102K | -99.40%93K | 267.26%11.79M | 479.14%15.42M | -163.57%-7.05M | -234.72%-4.07M | 5,231.73%11.09M | --3.02M | 144.71%208K | --85K |
Operating profit | -63.41%20.59M | -53.02%19.05M | 44.61%56.27M | 95.89%40.55M | -27.40%38.91M | 8.36%20.7M | 67.77%53.6M | 19.1M | 66.21%31.95M | 19.22M |
Financing income | 127.34%2.29M | --808K | 100,500.00%1.01M | ---- | -97.06%1K | -95.65%1K | -73.23%34K | --23K | 217.50%127K | --40K |
Financing cost | 78.89%-114K | 66.83%-69K | -285.71%-540K | -101.94%-208K | 83.39%-140K | 84.99%-103K | 39.87%-843K | ---686K | -99.15%-1.4M | ---704K |
Earning before tax | -59.88%22.76M | -50.94%19.79M | 46.33%56.74M | 95.85%40.34M | -26.55%38.77M | 11.70%20.6M | 72.11%52.79M | 18.44M | 65.29%30.67M | 18.56M |
Tax | 50.17%-3.69M | 21.20%-3.18M | 0.95%-7.41M | -5.33%-4.03M | -10.77%-7.48M | -63.95%-3.83M | -38.82%-6.75M | ---2.33M | -69.62%-4.86M | ---2.87M |
After-tax profit from continuing operations | -61.34%19.07M | -54.24%16.61M | 57.63%49.33M | 116.49%36.31M | -32.03%31.29M | 4.14%16.77M | 78.38%46.04M | 16.11M | 64.50%25.81M | 15.69M |
Earning after tax | -61.34%19.07M | -54.24%16.61M | 57.63%49.33M | 116.49%36.31M | -32.03%31.29M | 4.14%16.77M | 78.38%46.04M | 16.11M | 64.50%25.81M | 15.69M |
Profit attributable to shareholders | -61.34%19.07M | -54.24%16.61M | 57.63%49.33M | 116.49%36.31M | -32.03%31.29M | 4.14%16.77M | 78.38%46.04M | 16.11M | 64.50%25.81M | 15.69M |
Basic earnings per share | -66.67%0.019 | -64.58%0.017 | 35.71%0.057 | 118.18%0.048 | -96.44%0.042 | -94.63%0.022 | 78.79%1.18 | 0.41 | 65.00%0.66 | 0.4 |
Diluted earnings per share | -66.67%0.019 | -64.58%0.017 | 35.71%0.057 | 118.18%0.048 | -96.44%0.042 | -94.63%0.022 | 78.79%1.18 | 0.41 | 65.00%0.66 | 0.4 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data